Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA-directed RNA polymerase L (RSV L protein) is the large catalytic subunit of the respiratory syncytial virus (RSV) polymerase complex, essential for viral genome replication, transcription, and processing of viral mRNA. The protein (~250 kDa) comprises multiple functional domains: an RNA-dependent RNA polymerase (RdRp), a capping (PRNTase) domain, and a methyltransferase domain, which together orchestrate RNA synthesis, mRNA capping, methylation, and polyadenylation. RSV L associates with a tetrameric phosphoprotein (P) for full activity, forming a dynamic, multi-protein complex that precisely regulates initiation, elongation, and processing of RSV RNAs. Mutations in L are linked to resistance against polymerase inhibitors, making it a central focus for antiviral drug discovery against RSV infections
Inhibition of RNA-dependent RNA polymerization (blocks viral replication/transcription) Inhibition of capping/methylation enzymatic activities Allosteric inhibition or escape (some drugs induce mutations in L to escape inhibition)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA-directed RNA polymerase L (Respiratory syncytial virus) (RSV L protein).